申请人:Synta Pharmaceuticals Corp.
公开号:US20140248299A1
公开(公告)日:2014-09-04
The invention relates to compounds of structural formula (Ia):
or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X
1
, X
2
, X
3
, X
4
, X
6
, X
10
, R
1
, Y, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
本发明涉及结构式(Ia)的化合物:或其药学上可接受的盐、溶剂化合物、笼合物或前药,其中X1、X2、X3、X4、X6、X10、R1、Y、Z、L和n在此定义。这些化合物可用作免疫抑制剂,用于治疗和预防炎症性疾病、过敏性疾病和免疫性疾病。